Pande AH - Search Results

1

Human arginase I: a potential broad-spectrum anti-cancer agent.

Anakha J, Prasad YR, Sharma N, Pande AH. Anakha J, et al. Among authors: pande ah. 3 Biotech. 2023 May;13(5):159. doi: 10.1007/s13205-023-03590-3. Epub 2023 May 3. 3 Biotech. 2023. PMID: 37152001 Free PMC article. Review.

2

Antibiotic-free expression system for the production of human interferon-beta protein.

Pal D, Tripathy RK, Teja MS, Kumar M, Banerjee UC, Pande AH. Pal D, et al. Among authors: pande ah. 3 Biotech. 2018 Jan;8(1):36. doi: 10.1007/s13205-017-1056-3. Epub 2017 Dec 28. 3 Biotech. 2018. PMID: 29291149 Free PMC article.

3

Optimization of medium composition to increase the expression of recombinant human interferon-β using the Plackett-Burman and central composite design in E. coli SE1.

Pal D, Patel G, Dobariya P, Nile SH, Pande AH, Banerjee UC. Pal D, et al. Among authors: pande ah. 3 Biotech. 2021 May;11(5):226. doi: 10.1007/s13205-021-02772-1. Epub 2021 Apr 19. 3 Biotech. 2021. PMID: 33968571 Free PMC article.

4

Human arginase 1, a Jack of all trades?

Anakha J, Kawathe PS, Datta S, Jawalekar SS, Banerjee UC, Pande AH. Anakha J, et al. Among authors: pande ah. 3 Biotech. 2022 Oct;12(10):264. doi: 10.1007/s13205-022-03326-9. Epub 2022 Sep 7. 3 Biotech. 2022. PMID: 36082360 Free PMC article. Review.

5

Recombinant human endostatin as a potential anti-angiogenic agent: therapeutic perspective and current status.

Anakha J, Dobariya P, Sharma SS, Pande AH. Anakha J, et al. Among authors: pande ah. Med Oncol. 2023 Dec 21;41(1):24. doi: 10.1007/s12032-023-02245-w. Med Oncol. 2023. PMID: 38123873 Review.

6

Human paraoxonase 1 as a pharmacologic agent: limitations and perspectives.

Bajaj P, Tripathy RK, Aggarwal G, Pande AH. Bajaj P, et al. Among authors: pande ah. ScientificWorldJournal. 2014;2014:854391. doi: 10.1155/2014/854391. Epub 2014 Oct 20. ScientificWorldJournal. 2014. PMID: 25386619 Free PMC article. Review.

7

Organophosphate-Hydrolyzing Enzymes as First-Line of Defence Against Nerve Agent-Poisoning: Perspectives and the Road Ahead.

Iyengar AR, Pande AH. Iyengar AR, et al. Among authors: pande ah. Protein J. 2016 Dec;35(6):424-439. doi: 10.1007/s10930-016-9686-6. Protein J. 2016. PMID: 27830420 Review.

8

Expression and purification of biologically active recombinant human paraoxonase 1 from inclusion bodies of Escherichia coli.

Bajaj P, Tripathy RK, Aggarwal G, Pande AH. Bajaj P, et al. Among authors: pande ah. Protein Expr Purif. 2015 Nov;115:95-101. doi: 10.1016/j.pep.2015.05.011. Epub 2015 May 21. Protein Expr Purif. 2015. PMID: 26003526

9

Toward Understanding the Catalytic Mechanism of Human Paraoxonase 1: Site-Specific Mutagenesis at Position 192.

Aggarwal G, Prajapati R, Tripathy RK, Bajaj P, Iyengar AR, Sangamwar AT, Pande AH. Aggarwal G, et al. Among authors: pande ah. PLoS One. 2016 Feb 1;11(2):e0147999. doi: 10.1371/journal.pone.0147999. eCollection 2016. PLoS One. 2016. PMID: 26829396 Free PMC article.

10

Refolded Recombinant Human Paraoxonase 1 Variant Exhibits Prophylactic Activity Against Organophosphate Poisoning.

Bajaj P, Tripathy RK, Aggarwal G, Datusalia AK, Sharma SS, Pande AH. Bajaj P, et al. Among authors: pande ah. Appl Biochem Biotechnol. 2016 Sep;180(1):165-76. doi: 10.1007/s12010-016-2091-y. Epub 2016 Apr 30. Appl Biochem Biotechnol. 2016. PMID: 27131877

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

72 results

Search Page